The luteal phase in polycystic ovary syndrome during ovulation induction with human menopausal gonadotropin with human menopausal gonadotropin with and without leuprolide acetate

K. E. Bachus, C. L. Hughes, A. F. Haney, William Dodson

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

Little data exist on the effects of adjunctive therapy with leuprolide acetate (LA) in the luteal phase of women with polycystic ovary syndrome (PCOS) undergoing ovulation induction with human menopausal gonadotropin (hMG). Additionally, it is not known whether gonadal steroid concentrations in the luteal phase of induced cycles in PCOS are predictive of pregnancy. In this prospective, randomized study comparing cycles using hMG alone (n = 26) with cycles using hMG with LA (n = 33), no differences were noted between treatment groups in progesterone (P), estradiol (E2), and P:E2 ratios on luteal days 3, 6, and 9. When all treatment cycles were pooled, there were no differences in P, E2, or P:E2 ratios, comparing conception and nonconception cycles. We conclude that adjunctive therapy with LA in PCOS patients undergoing ovulation induction with hMG does not alter the luteal phase concentrations of P, E2, and P:E2. Furthermore, no correlation was found between the serum concentrations of these luteal phase steroids and cycle fecundity.

Original languageEnglish (US)
Pages (from-to)27-31
Number of pages5
JournalFertility and sterility
Volume54
Issue number1
StatePublished - Jan 1 1990

Fingerprint

Leuprolide
Menotropins
Ovulation Induction
Polycystic Ovary Syndrome
Luteal Phase
Steroids
Corpus Luteum
Therapeutics
Progesterone
Fertility
Estradiol
Prospective Studies
Pregnancy
Serum

All Science Journal Classification (ASJC) codes

  • Reproductive Medicine
  • Obstetrics and Gynecology

Cite this

@article{a27bb5267a6e4a889d29e3b28fc1a3db,
title = "The luteal phase in polycystic ovary syndrome during ovulation induction with human menopausal gonadotropin with human menopausal gonadotropin with and without leuprolide acetate",
abstract = "Little data exist on the effects of adjunctive therapy with leuprolide acetate (LA) in the luteal phase of women with polycystic ovary syndrome (PCOS) undergoing ovulation induction with human menopausal gonadotropin (hMG). Additionally, it is not known whether gonadal steroid concentrations in the luteal phase of induced cycles in PCOS are predictive of pregnancy. In this prospective, randomized study comparing cycles using hMG alone (n = 26) with cycles using hMG with LA (n = 33), no differences were noted between treatment groups in progesterone (P), estradiol (E2), and P:E2 ratios on luteal days 3, 6, and 9. When all treatment cycles were pooled, there were no differences in P, E2, or P:E2 ratios, comparing conception and nonconception cycles. We conclude that adjunctive therapy with LA in PCOS patients undergoing ovulation induction with hMG does not alter the luteal phase concentrations of P, E2, and P:E2. Furthermore, no correlation was found between the serum concentrations of these luteal phase steroids and cycle fecundity.",
author = "Bachus, {K. E.} and Hughes, {C. L.} and Haney, {A. F.} and William Dodson",
year = "1990",
month = "1",
day = "1",
language = "English (US)",
volume = "54",
pages = "27--31",
journal = "Fertility and Sterility",
issn = "0015-0282",
publisher = "Elsevier Inc.",
number = "1",

}

TY - JOUR

T1 - The luteal phase in polycystic ovary syndrome during ovulation induction with human menopausal gonadotropin with human menopausal gonadotropin with and without leuprolide acetate

AU - Bachus, K. E.

AU - Hughes, C. L.

AU - Haney, A. F.

AU - Dodson, William

PY - 1990/1/1

Y1 - 1990/1/1

N2 - Little data exist on the effects of adjunctive therapy with leuprolide acetate (LA) in the luteal phase of women with polycystic ovary syndrome (PCOS) undergoing ovulation induction with human menopausal gonadotropin (hMG). Additionally, it is not known whether gonadal steroid concentrations in the luteal phase of induced cycles in PCOS are predictive of pregnancy. In this prospective, randomized study comparing cycles using hMG alone (n = 26) with cycles using hMG with LA (n = 33), no differences were noted between treatment groups in progesterone (P), estradiol (E2), and P:E2 ratios on luteal days 3, 6, and 9. When all treatment cycles were pooled, there were no differences in P, E2, or P:E2 ratios, comparing conception and nonconception cycles. We conclude that adjunctive therapy with LA in PCOS patients undergoing ovulation induction with hMG does not alter the luteal phase concentrations of P, E2, and P:E2. Furthermore, no correlation was found between the serum concentrations of these luteal phase steroids and cycle fecundity.

AB - Little data exist on the effects of adjunctive therapy with leuprolide acetate (LA) in the luteal phase of women with polycystic ovary syndrome (PCOS) undergoing ovulation induction with human menopausal gonadotropin (hMG). Additionally, it is not known whether gonadal steroid concentrations in the luteal phase of induced cycles in PCOS are predictive of pregnancy. In this prospective, randomized study comparing cycles using hMG alone (n = 26) with cycles using hMG with LA (n = 33), no differences were noted between treatment groups in progesterone (P), estradiol (E2), and P:E2 ratios on luteal days 3, 6, and 9. When all treatment cycles were pooled, there were no differences in P, E2, or P:E2 ratios, comparing conception and nonconception cycles. We conclude that adjunctive therapy with LA in PCOS patients undergoing ovulation induction with hMG does not alter the luteal phase concentrations of P, E2, and P:E2. Furthermore, no correlation was found between the serum concentrations of these luteal phase steroids and cycle fecundity.

UR - http://www.scopus.com/inward/record.url?scp=0025288665&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025288665&partnerID=8YFLogxK

M3 - Article

C2 - 2113488

AN - SCOPUS:0025288665

VL - 54

SP - 27

EP - 31

JO - Fertility and Sterility

JF - Fertility and Sterility

SN - 0015-0282

IS - 1

ER -